47 research outputs found
Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.
Insulin resistance is often associated with atherosclerotic diseases in subjects with obesity and impaired glucose tolerance. This study examined the effects of insulin resistance on coronary risk factors in IRS-1 deficient mice, a nonobese animal model of insulin resistance. Blood pressure and plasma triglyceride levels were significantly higher in IRS-1 deficient mice than in normal mice. Impaired endothelium-dependent vascular relaxation was also observed in IRS-1 deficient mice. Furthermore, lipoprotein lipase activity was lower than in normal mice, suggesting impaired lipolysis to be involved in the increase in plasma triglyceride levels under insulin-resistant conditions. Thus, insulin resistance plays an important role in the clustering of coronary risk factors which may accelerate the progression of atherosclerosis in subjects with insulin resistance
「方丈の庵」の居住空間のデザインに関する実践的研究
1212 年、鴨長明は「方丈記」を記した。それは、厭世感を表現したもので、わずか3 メートル四方の「方丈の庵」で書かれたと伝えられている。それゆえ、「方丈の庵」には余分な機能はなく日本の住まいの原形としてとらえられている。このような点から、本研究では、「方丈の庵」を日本人の住まいの原形としてとらえ、地域学習の対象として活用することにより、住まいに関する現代的な知見を得ることを目的とする。なかでも、近年の環境と共生する住まいのあり方とその思想の接点を考察するものである。研究のフィールドは、神戸市西区「みついけプロジェクト」周辺地区とし、都市再生機構が管理する学園南緑地里山エリアを拠点とした。そこは地域交流の拠点として位置付けられており、様々なワークショップやイベントが計画されている。本研究で計画している「方丈の庵」の製作およびその活用は、地域交流の今後の指針となることが期待されている。研究方法は、①知識の共有、②施工ワークショップという2 段階を計画、実施した。このことにより、建築を通じた地域学習のあり方としても新たな展開を示したと考えられる。"Hojoki" was written by KAMO no Chomei at “Ho-o hermitage” in 1212. There is a philosophy based on a pessimistic view of life. But that hermitage is not the extra function and is the original form of the house of Japan.The aim of this study is obtained to knowledge about contemporary lifestyle by inflecting as an object of the regional study through “Hojo hermitage”.The subject of the research is “Mitsuike area”: Nishi ward, Kobe city. This study based at Satoyama of South Green area; it had been placed as a base of the regional study at “Mitsuike area”, and various workshops and events were planned.The study method planned two phases, ① shared knowledge of “Hojo hermitage” ②construction workshop of “Hojo hermitage”. By this method, there is new development as the role of the regional study through the building
Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force
「コロナ制圧タスクフォース」COVID-19患者由来の血液細胞における遺伝子発現の網羅的解析 --重症度に応じた遺伝子発現の変化には、ヒトゲノム配列の個人差が影響する--. 京都大学プレスリリース. 2022-08-23.Coronavirus disease 2019 (COVID-19) is a recently-emerged infectious disease that has caused millions of deaths, where comprehensive understanding of disease mechanisms is still unestablished. In particular, studies of gene expression dynamics and regulation landscape in COVID-19 infected individuals are limited. Here, we report on a thorough analysis of whole blood RNA-seq data from 465 genotyped samples from the Japan COVID-19 Task Force, including 359 severe and 106 non-severe COVID-19 cases. We discover 1169 putative causal expression quantitative trait loci (eQTLs) including 34 possible colocalizations with biobank fine-mapping results of hematopoietic traits in a Japanese population, 1549 putative causal splice QTLs (sQTLs; e.g. two independent sQTLs at TOR1AIP1), as well as biologically interpretable trans-eQTL examples (e.g., REST and STING1), all fine-mapped at single variant resolution. We perform differential gene expression analysis to elucidate 198 genes with increased expression in severe COVID-19 cases and enriched for innate immune-related functions. Finally, we evaluate the limited but non-zero effect of COVID-19 phenotype on eQTL discovery, and highlight the presence of COVID-19 severity-interaction eQTLs (ieQTLs; e.g., CLEC4C and MYBL2). Our study provides a comprehensive catalog of whole blood regulatory variants in Japanese, as well as a reference for transcriptional landscapes in response to COVID-19 infection
ホウシャセン チリョウジ ノ ハッケッキュウ ゲンショウ ニ タイスル Z-100 ノ リンショウ コウカ タシセツ ニジュウ モウケンホウ ニヨル イノシン トノ ヒカク
ホウシャセン チリョウジ ノ ハッケッキュウ ゲンショウ ニ タイスル Z-100 ノ リンショウ コウカ タシセツ ニジュウ モウケンホウ ニヨル L-システイン トノ ヒカク
DOCK2 is involved in the host genetics and biology of severe COVID-19
「コロナ制圧タスクフォース」COVID-19疾患感受性遺伝子DOCK2の重症化機序を解明 --アジア最大のバイオレポジトリーでCOVID-19の治療標的を発見--. 京都大学プレスリリース. 2022-08-10.Identifying the host genetic factors underlying severe COVID-19 is an emerging challenge. Here we conducted a genome-wide association study (GWAS) involving 2, 393 cases of COVID-19 in a cohort of Japanese individuals collected during the initial waves of the pandemic, with 3, 289 unaffected controls. We identified a variant on chromosome 5 at 5q35 (rs60200309-A), close to the dedicator of cytokinesis 2 gene (DOCK2), which was associated with severe COVID-19 in patients less than 65 years of age. This risk allele was prevalent in East Asian individuals but rare in Europeans, highlighting the value of genome-wide association studies in non-European populations. RNA-sequencing analysis of 473 bulk peripheral blood samples identified decreased expression of DOCK2 associated with the risk allele in these younger patients. DOCK2 expression was suppressed in patients with severe cases of COVID-19. Single-cell RNA-sequencing analysis (n = 61 individuals) identified cell-type-specific downregulation of DOCK2 and a COVID-19-specific decreasing effect of the risk allele on DOCK2 expression in non-classical monocytes. Immunohistochemistry of lung specimens from patients with severe COVID-19 pneumonia showed suppressed DOCK2 expression. Moreover, inhibition of DOCK2 function with CPYPP increased the severity of pneumonia in a Syrian hamster model of SARS-CoV-2 infection, characterized by weight loss, lung oedema, enhanced viral loads, impaired macrophage recruitment and dysregulated type I interferon responses. We conclude that DOCK2 has an important role in the host immune response to SARS-CoV-2 infection and the development of severe COVID-19, and could be further explored as a potential biomarker and/or therapeutic target